BioArctic AB (OSTO:BIOA B) Moat Score : 5/10 (As of Jul. 19, 2025)

View and export this data going back to 2017. Start your Free Trial

What is BioArctic AB Moat Score?

BioArctic AB has the Moat Score of 5, which implies that the company might have Narrow Moat - Solid narrow moat.

BioArctic AB has Narrow Moat: BioArctic AB has valuable intellectual property and patents in the biotechnology sector. The company benefits from strong R&D capabilities and regulatory barriers, but lacks the scale and market dominance for a wide moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes BioArctic AB might have Narrow Moat - Solid narrow moat.

Competitive Comparison of BioArctic AB's Moat Score

For the Biotechnology subindustry, BioArctic AB's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioArctic AB's Moat Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioArctic AB's Moat Score distribution charts can be found below:

* The bar in red indicates where BioArctic AB's Moat Score falls into.

Save Embed

;

Save Embed

;

BioArctic AB (OSTO:BIOA B) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score	Moat Level
10	Wide Moat - Exceptionally dominant and durable wide moat
8 - 9	Wide Moat - Clear and robust wide moat
7	Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6	Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5	Narrow Moat - Solid narrow moat
4	Narrow Moat - Discernible but modest moat
1 - 3	No Moat - Very weak/transient advantages
0	No Moat - No discernible moat

BioArctic AB Moat Score Related Terms

Thank you for viewing the detailed overview of BioArctic AB's Moat Score provided by GuruFocus.com. Please click on the following links to see related term pages.

BioArctic AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioArctic AB (OSTO:BIOA B) » Definitions » Moat Score

Comparable Companies

Traded in Other Exchanges

BRCTF:USA BIOABs:UK 0RV2:UK B9A:Germany

Address

Warfvinges vag 35, Stockholm, SWE, SE-112 51

Website

https://www.bioarctic.se

BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. In addition, the group is also focused on the development of a treatment with a combination of a biodegradable medical device and a drug substance for complete spinal cord injury. Geographically, it derives a majority of its revenue from Asia.

BioArctic AB Headlines

No Headlines